Jeffrey D Milbrandt

Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA.

PierianDx, Inc. provides genomic software and services. It develops a platform to manage, analyze, and interpret complex genomic tests for clinical laboratories across the United States. The firm?s genomics software platform, Clinical Genomicist Workstation (CGW), provides data-driven workflow for health systems, academic medical centers, and commercial labs to improve patient outcomes through genomic analysis, interpretation and reporting. The company was founded by Jeffrey D. Milbrandt, Karen Seibert, John D. Pfeifer, Herbert W. Virgin, and Rakesh Nagarajan in 2014 and is headquartered in St. Louis, MO.